Kento Asano

Suita, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Effect of Nicotinamide Mononucleotide on Retinal Thickness of Older Patients With Diabetes Mellitus: A Placebo-Controlled, Double-Blind Study.

Effect of Nicotinamide Mononucleotide on Retinal Thickness of Older Patients With Diabetes Mellitus: A Placebo-Controlled, Double-Blind Study.

Journal: Geriatrics & gerontology international

Published: December 05, 2025

Research to evaluate safety and impact of long COVID intervention with Ensitrelvir for National Cohort (RESILIENCE Study): A protocol for a randomized, double-blind, placebo-controlled trial.

Research to evaluate safety and impact of long COVID intervention with Ensitrelvir for National Cohort (RESILIENCE Study): A protocol for a randomized, double-blind, placebo-controlled trial.

Journal: PloS one

Published: April 21, 2025

KRAS Mutations in Duodenal Lavage Fluid after Secretin Stimulation for Detection of Pancreatic Cancer.

KRAS Mutations in Duodenal Lavage Fluid after Secretin Stimulation for Detection of Pancreatic Cancer.

Journal: Annals of surgery

Published: February 04, 2025

Cross-sectional surveillance study of long COVID in Toyonaka city, Osaka prefecture, Japan.

Cross-sectional surveillance study of long COVID in Toyonaka city, Osaka prefecture, Japan.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: September 04, 2023

Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study.

Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study.

Journal: Geriatrics & gerontology international

Published: September 08, 2022

Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan.

Botulinum Toxin Therapy: A Series of Clinical Studies on Patients with Spasmodic Dysphonia in Japan.

Journal: Toxins

Published: October 31, 2021

Post-treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo-controlled, randomized, double-blinded clinical trial in Japan.

Post-treatment clinical course following botulinum toxin injection therapy for adductor spasmodic dysphonia: Analysis of data from a placebo-controlled, randomized, double-blinded clinical trial in Japan.

Journal: Laryngoscope investigative otolaryngology

Published: June 06, 2021

Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo-controlled, randomized, double-blinded, parallel-group comparison/open-label clinical trial.

Botulinum toxin injection into the intrinsic laryngeal muscles to treat spasmodic dysphonia: A multicenter, placebo-controlled, randomized, double-blinded, parallel-group comparison/open-label clinical trial.

Journal: European journal of neurology

Published: August 21, 2020

Performance Index for Types of Clinical Research Support Service Providers for Academic Research Organizations in Japan: A Cross-Sectional Survey.

Performance Index for Types of Clinical Research Support Service Providers for Academic Research Organizations in Japan: A Cross-Sectional Survey.

Journal: Clinical and translational science

Published: July 16, 2020

The prevalence and clinical features of spasmodic dysphonia: A review of epidemiological surveys conducted in Japan.

The prevalence and clinical features of spasmodic dysphonia: A review of epidemiological surveys conducted in Japan.

Journal: Auris, nasus, larynx

Published: May 03, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026